Aulos Bioscience, an immuno-oncology company focused on advancing cancer care through innovative IL-2 therapeutics, has announced the presentation of encouraging safety and efficacy data from the Phase 2 dose expansion…
Summit Therapeutics Inc. (NASDAQ: SMMT) has announced the completion of patient enrollment in its HARMONi clinical trial. This multi-regional Phase III study evaluates ivonescimab combined with platinum-doublet chemotherapy versus placebo…
CureMetrix® has announced a new peer-reviewed study confirming the effectiveness of its investigational AI-enabled software for automated breast arterial calcification (BAC) detection in mammograms. This technology can inform personalized risk…
StemCardia Inc. has secured a license for a range of intellectual property from CoMotion at the University of Washington (UW) and the UW School of Medicine, focusing on next-generation treatments…
Henry Schein, Inc. (Nasdaq: HSIC), the leading provider of health care solutions for dental and medical practitioners, has unveiled the “Prepare to Care” initiative through the Henry Schein Cares Foundation,…
Superior HealthPlan, a prominent managed care organization in Texas and part of Centene Corporation (NYSE: CNC), has launched a new screening tool designed to help Texans access community resources more…
Varian, a Siemens Healthineers company, has announced a 10-year agreement with Ballad Health to enhance oncology treatment services for patients in rural communities across the Appalachian Highlands, including Northeast Tennessee,…
HCA Healthcare, Inc. (NYSE:HCA), a leading healthcare provider in the nation, presented its annual HCA Healthcare Awards of Distinction during a ceremony in Nashville, Tennessee. These awards, including the Frist…
Naveris, Inc., a leader in precision oncology diagnostics for viral-induced cancers, announced new data presentation at the 2024 Annual Meeting of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS),…
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company focused on enhancing women’s health, has received U.S. FDA approval for the use of Motiva® SmoothSilk® Ergonomix® and Motiva®…
Phare Bio, in collaboration with the Collins Lab at MIT and Harvard’s Wyss Institute, announced they have secured up to $27 million in funding from the Advanced Research Projects Agency…
CleanNA, a leading Dutch manufacturer of magnetic bead-based nucleic acid extraction kits, has unveiled a CE-IVD compliant version of its flagship product, CleanNGS. The new CleanNGS Dx reagent is designed…